Bioresponsive Hyaluronic Acid‐Based Hydrogel Inhibits Matrix Metalloproteinase‐2 in Glioblastoma Microenvironment
ChemMedChem · 02.08.2025 · 20 (15)
DOI: 10.1002/cmdc.202401040 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 24.06.2025. Verfasst von Federica Barbugian und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Surgery, Università di Milano-Bicocca, 20900, Monza (MB), Italy. Hauptthemen laut MEDLINE: Hyaluronic Acid, Glioblastoma, Hydrogels, Matrix Metalloproteinase 2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca, Dipartimenti di Eccellenza 2023-2027.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) is an extremely malignant cancer, resistant to standard therapies. Tumor resection is associated with better outcomes but a complete resection of GBMs is challenging for anatomical limitation and for the high degree of invasiveness. A bioresponsive hydrogel based on hyaluronic acid (HA) cross‐linked with a branched metalloproteinase (MMP) inhibitor (MMPI) is proposed. The fully characterized hydrogel, HA‐MMPI, presents physical properties suitable for filling the surgical resection cavity and for in situ delivery of the inhibitor. The bioresponsive material selectively inhibits MMP‐2 versus MMP‐9 in glioblastoma microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine and Surgery, Università di Milano-Bicocca, 20900, Monza (MB), Italy.
- Department of Chemistry, University of Florence, Polo Scientifico e Tecnologico, Firenze, 50019, Sesto Fiorentino, Italy.
- INSTM, Consorzio Interuniversitario per la Scienza e Tecnologia dei Materiali, Via Giusti, 9, 50021, Firenze, Italy.
- Department of Biotechnology, Chemistry and Pharmacy, Università degli Studi di Siena, 53100, Siena, Italy.
ORCID-Profile: Domenico Salerno, Oscar Francesconi, Francesco Mantegazza, Guido Cavaletti, Agnese Magnani, Cristina Nativi, Laura Russo
Förderung
- Ministero dell'Università e della Ricerca
- Dipartimenti di Eccellenza 2023-2027
Zitieren
APA
Barbugian, F., Salerno, D., Ballarini, E., Crippa, L., Francesconi, O., Mantegazza, F., Cavaletti, G., Roelens, S., Leone, G., Pepi, S., Talarico, L., Magnani, A., Nativi, C., & Russo, L. (2025). Bioresponsive Hyaluronic Acid‐Based Hydrogel Inhibits Matrix Metalloproteinase‐2 in Glioblastoma Microenvironment. ChemMedChem, 20(15). https://doi.org/10.1002/cmdc.202401040
Vancouver
Barbugian F, Salerno D, Ballarini E, Crippa L, Francesconi O, Mantegazza F, et al. Bioresponsive Hyaluronic Acid‐Based Hydrogel Inhibits Matrix Metalloproteinase‐2 in Glioblastoma Microenvironment. ChemMedChem. 2025;20(15). doi:10.1002/cmdc.202401040
BibTeX
@article{Barbugian2025,
author = {Barbugian, Federica and Salerno, Domenico and Ballarini, Elisa and Crippa, Luca and Francesconi, Oscar and Mantegazza, Francesco and Cavaletti, Guido and Roelens, Stefano and Leone, Gemma and Pepi, Simone and Talarico, Luigi and Magnani, Agnese and Nativi, Cristina and Russo, Laura},
title = {Bioresponsive Hyaluronic Acid‐Based Hydrogel Inhibits Matrix Metalloproteinase‐2 in Glioblastoma Microenvironment},
journal = {ChemMedChem},
year = {2025},
volume = {20},
number = {15},
doi = {10.1002/cmdc.202401040}
}
EUVIMED